Treatment resistant schizophrenia (TRS) has a severe clinical and economic impact on patients, carers, families and society as the whole. Research on TRS has generated several hypotheses to explain the underlying pathophysiology. This video provides an overview of one such hypothesis.
Related content
Brain Insulin Action and Metabolic Dysregulation in Schizophrenia: From Mechanistic Insights to Novel Interventions
The complex interplay between metabolic dysfunction and brain insulin resistance in schizophrenia warrants further investigation as it represents a unique opportunity for both mechanistic inquiry and the development of novel therapeutic strategies that can improve metabolic and cognitive outcomes in this population.
24.10.2025
Schizophrenia
Central and peripheral causes of brain insulin resistance in schizophrenia
Central and peripheral causes of brain insulin resistance in schizophrenia
24.10.2025
Schizophrenia
